Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Full phase II results of uPAR-PET in glioblastoma published

Curasight has published the full data from an investigator-initiated phase II trial evaluating its uTRACE imaging technology in brain cancer patients in the peer-reviewed journal EJNMMI Research. The results – which were first reported in connection with an oral presentation at a conference last year – supports the strategy to develop uTRACE and the therapeutic uTREAT in parallel.Read the full article at biostock.se: https://www.biostock.se/en/2024/11/full-phase-ii-results-of-upar-pet-in-glioblastoma-published/ This is a press release from BioStock - Connecting Innovation & Capital.

Notification of Executive’s transaction with Vestas shares

Vestas Wind Systems A/S, Aarhus, 8 November 2024Company Announcement no. 18/2024 In accordance with Article 19 (3) of the EU Market Abuse Regulation, Vestas Wind Systems A/S is required to disclose information regarding trading in Vestas Wind Systems A/S shares and securities by Executives and persons closely associated with an Executive. The statement is based on a report which Vestas Wind Systems A/S has received from one of the Executives, see appendix. Contact detailsVestas Wind Systems A/S, Denmark Daniel Patterson, Vice PresidentInvestor RelationsTel: +45 2669 2725

WindowMaster International A/S wins new contract for specialdesigned Kindergarten in Karlsruhe, Germany

Investor News No. 038 - 2024WindowMaster has won a new contract for a kindergarten that will be offering space for 110 preschool children in Karlsruhe, Germany. The order will bring fresh air into 1.900 square meters of floor space designed by experts, counting multi-purpose rooms, kitchen, sanitary facilities and a bistro. NV Advance[®] will be controlling the fresh air supply in 33 zones using 100 whisper-quiet WMX 814 window drives. The WindowMaster solution will also be controlling the smoke extraction, through CompactSmoke control units, and the solar shading. This project win

Irisity AB (publ) publishes prospectus due to upcoming preferential share issue

NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, THE UNITED STATES OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION, OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Irisity AB (publ) (“Irisity” or the “Company”) announced on 1 October 2024, its intention to resolve on rights issue of units

Join Big Betty Partners at Sigma Europe 2024 – The Ultimate iGaming Event!

Big Betty Partners , a standout affiliate program known for delivering top-tier benefits to its partners, remains dedicated to reliable payouts and personalized support for every affiliate. As a rapidly growing force in affiliate marketing for iGaming operators worldwide, Big Betty Partners is set to unveil exciting innovations and share plans at the Sigma Europe 2024 in Malta, which will take place from November 11th to 14th.Meet

Nordic Aqua - Invitation to presentation of third quarter 2024 results

Nordic Aqua Partners AS will release its Q3 2024 results on Thursday, November 14, 2024, at 7:00 a.m. CET. The quarterly report and the presentation materials will be available on the company's website, https://www.nordicaquapartners.com/en/investor and on www.newsweb.no. The same day at 10:00 a.m. CET, the company will host a webcast to present the results. Following the presentation, it will be opened for questions from the audience. The Company will be represented by Ragnar Joensen, CEO, Andreas Thorud, Managing Director Nordic Aqua (Ningbo) and Tom Johan Austrheim, CFO. The

QVance AB Publishes Article on Particulates in Cell and Gene Therapy Products in Collaboration with ISCT

NextCell Pharma AB* announces that its subsidiary, QVance AB, has published an article in collaboration with the International Society of Cell and Gene Therapy (ISCT). The article, authored by Dr. Lindsay Davies, CSO at NextCell and co-founder of QVance, was published in Cytotherapy and is based on a global survey examining knowledge on particulates in cell and gene therapy (CGT) products.QVance, founded by cell therapy developers to support other cell therapy developers, aims to become the leading quality analysis company for CGT in the Nordic region. With NextCell’s expertise as a

Henrik Samuelson elected FoodDrinkEurope President

FoodDrinkEurope has today announced the appointment of Henrik Samuelson, SVP Customer Brands at Paulig, as its new President. Today, FoodDrinkEurope announced the appointment of Henrik Samuelson, SVP Customer Brands at Paulig, as its new President.  Henrik was elected by FoodDrinkEurope's Board of Directors, which convened on November 8th. He takes over from Marco Settembri, former Nestlé CEO Zone Europe, who held the position of President at FoodDrinkEurope since 2020. FoodDrinkEurope is the organisation of Europe’s food and drink industry,  Henrik Samuelson will

Global Fashion Summit debuts in China, calling for global collaboration on sustainability

8 November 2024: Global Fashion Summit , the international forum for sustainability in fashion, presented a special Shanghai Gala  edition on 7 November during the China International Import Expo (CIIE). The event was presented by Global Fashion Agenda  (GFA) and Chinamind NEXT and gathered key local and international fashion industry stakeholders for an evening of compelling discussions during a gala dinner at The St. Regis Shanghai Jingan.Global

Director/PDMR Shareholding

Fidelity Emerging Markets Ltd Director Shareholding The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation 1 Details of the person discharging managerial  responsibilities / person closely associated  a) Name Ms Katherine Tsang     2 Reason for the notification    a) Position/status Non-executive director (PDMR)     b) Initial notification Initial notification /Amendment    3 Details of the issuer, emission

Emerging Esports Betting: New Games Shaping the Future of Betting Markets

Stockholm, Sweden, November 2024 – eSportRanker, a pioneering authority in esports wagering, is thrilled to announce the release of its latest report, “Betting on the Next Big Thing: How Emerging Esports Titles Disrupt Betting Markets.” This comprehensive analysis sheds light on the transformative impact of new esports titles, such as Valorant, Wild Rift, and Apex Legends, which are reshaping betting markets with fresh gameplay dynamics and rapidly growing fan bases. The report explores how these games are challenging traditional betting practices, providing fresh opportunities for fans, and

BEWI ASA – Mandatory notification of trade by close associate of primary insider

By a group internal transaction, Conchilia AS, a company in which Kverva Industrier AS has an ownership interest of approximately 70%, has sold 267,600 shares in BEWI ASA to Kverva Industrier AS at a price of NOK 24,54 per share. Following this, Kverva Industrier AS owns 15,560,024 shares (8.12%) in BEWI ASA. In addition, Kverva AS is a party to total return swap agreement with a third party under which Kverva AS has a financial exposure to 9,092,220 shares (4.74%) in BEWI ASA, resulting in Kverva AS having a total BEWI ASA exposure equal to 24,652,244 shares (12.86%). Kverva

Rottneros sells emission allowances

Rottneros continues to sell emission allowances. In addition to the sales in September, which the Group reported on in the report for the third quarter of 2024, emission allowances for 44 MSEK have so far been sold in the fourth quarter. The company intends to sell additional emission allowances for approximately 18 MSEK during the current quarter, provided that market conditions are deemed favorable.   Executed and planned sales of emission allowances are distributed as follows:                                                                                         Amount

Italian boutique airline SkyAlps to launch a new route from Gothenburg Landvetter Airport to Bolzano in January 2025

Ahead of winter of 2025, SkyAlps is launching a new direct route from Gothenburg Landvetter Airport to Bolzano, Italy. Starting on January 18th, SkyAlps will operate the route once a week, on Saturdays, and whisk passengers to Italy in just about two and a half hours.Located in Northern Italy, in the South Tyrol region, Bolzano is near both the Dolomites and the Garda Lake, making it a perfect destination for those wanting to explore the Italian countryside. Working closely with the tour operator Slopestar, SkyAlps will offer the western of Sweden easy access to snowy slopes in the Italian

The liquidity providing service for Wetteri Plc's share ends

Wetteri Plc Stock Exchange Release 8 November 2024 at 13.00Wetteri Plc has terminated the liquidity providing service with Lago Kapital Oy to end on 8 January 2025. The Company estimates that the liquidity of the share is sufficient without market making. More information Aarne Simula, CEO and President, Wetteri Plc: Tel. +358 400 689 613, aarne.simula@wetteri.fi Wetteri Plc – an entrepreneur-driven growth company in the automotive sector Wetteri Plc is an entrepreneur-driven growth company in the automotive sector. The company engages in the retail sales of passenger cars,

Implantica presents the third quarter 2024 on November 15 at 15:00 CEST

Implantica AG (publ) invites investors to a presentation of the third quarter 2024 at 15:00 CET on November 15. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.The presentation will be in English via an audiocast with teleconference: If you wish to participate via webcast, please use the following link: · https://ir.financialhearings.com/implantica-q3-report-2024 If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the

AcuCort reschedules publication date for third quarter interim report

AcuCort has postponed the publication of its third-quarter interim report to November 29, 2024. The report was initially scheduled for release on November 22.AcuCort previously announced that the company would present the results of the study "Swedish Allergists' View on the Role of Cortisone and the Formulation (Tablets or Self-Dissolving Film) for the Treatment of Acute Allergic Reactions" at the ISPOR scientific conference in Barcelona.   Due to the high level of interest in the study’s results, AcuCort's CEO, Jonas Jönmark, will attend the conference in Barcelona from November 17–

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BMZR7D19 Issuer Name ASHOKA WHITEOAK EMERGING MARKETS TRUST PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Evelyn Partners Limited City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the

Curasight to present at Dansk Aktionærforening InvestorDagen

Copenhagen, Denmark, 8 November 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich Krasilnikoff and CMO Andreas Kjær have been invited to present the company’s latest progress and strategy at Dansk Aktionærforening InvestorDagen in Copenhagen 11 November 2024Management will give an overall update on the company’s pipeline based on the proprietary uPAR theranostics platform and focused on diagnosing and treating cancer, and its view on the newly published peer-reviewed data in the journal EJNMMI Research from the Phase II uTRACE trial in

NRC Group ASA – Final result of the Subsequent Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange notice from NRC Group ASA (the "Company") on 24 October 2024 regarding the commencement of the subscription period (the "Subscription Period") in the subsequent offering (the "Subsequent Offering") consisting of up to 20,000,000

Bulletin from the extraordinary general meeting, and the second control meeting, in Qlife Holding AB on 8 November 2024

Today, on 8 November 2024, an extraordinary general meeting, and the second control meeting, was held in Qlife Holding AB. A summary of the adopted resolutions follows below.Resolution on whether the company shall enter into liquidation or continue its operations It was noted that the second control balance sheet shows that the company's total equity is fully restored. On that basis, the extraordinary general meeting resolved in accordance with the primary proposal from the board of directors that the company’s operations shall be continued. Resolution on amendment of the Articles of

LINK Arkitektur wins major school project in Bærum

Multiconsult's (Oslo: MULTI) fully owned subsidiary LINK Arkitektur AS has entered into an agreement with Vedal Entreprenør AS to design a school in Bærum for Akershus County Municipality, Norway.Akershus County Municipality will construct and rehabilitate Rud upper secondary school. The new school will accommodate an increase of approximately 450 student places, bringing the total capacity to 1 300 students. The new building will cover approximately 21 000 m² of space, while the existing building, covering about 1 800 m², will undergo rehabilitation. The project will be carried out as a

Update to Financial Calendar

White Pearl Technology Group AB (WPTG) announces an update to its financial calendar. The Q3 2024 report will be published on Monday, 11 November 2024.Updated Financial Calendar · Q3 2024 Report: 11 November 2024 · Year-end Report 2024: 28 February 2025 (unchanged) All other dates in the financial calendar remain unchanged. For the complete financial calendar, please visit our website at www.whitepearltech.com. For further information, please contact: Investor Relations White Pearl Technology Group AB Email: ir@whitepearltech.com Phone: +46 707 340804 About

Dicot Pharma announces initiation of Phase 2a clinical study

Uppsala, Sweden, November 8, 2024. After recently receiving approval from authorities, the potency drug developer Dicot Pharma's clinical phase 2a study has now started. The primary objective of the study is to evaluate the efficacy of LIB-01 in patients with erectile dysfunction.Recruitment for the phase 2a study began immediately after the authority's approval and is managed by the company's clinical partner CTC, which is conducting the study.  Now the company announces that the study has formally started as the first screening visit has taken place. The primary objective of the phase

There are no items matching the current filter
There are no more items matching the current filter
Back to top